TYK MEDICINES-B 02410·

Gross margin 45.30%------13.08%------ Net margin -704.76%-------362549.53%------ ROE 61.47%--43.24%18.23%-82.49%125.73%-104.57%22.08% ROA -55.84%---66.85%11.01%-42.36%24.49%-39.24%3.12% Attributable profit growth -----22.97%---1.18%21.79%22.53%23.72% Debt-to-assets 189.68%--253.55%63.86%48.39%205.15%63.24%14.85% Current ratio 0.29--0.180.111.971.791.430.54 Operating cash flow / net profit 0.71--0.520.180.790.270.710.09 Operating cash flow / revenue -497.38%-------288085.98%------

Attributable profit growth ----77.81%-- Debt-to-assets ----66.07%-- Current ratio ----1.05-- Operating cash flow / net profit ----3.39--

Revenue 44.24M------107.00K------ Other income and gains 16.22M--25.43M56.74%30.54M20.11%37.61M23.14% Gross profit 20.04M------14.00K------ Administrative expenses 33.54M--59.31M76.83%108.33M82.67%78.48M27.56% Net finance costs 15.51M--22.24M43.40%12.82M42.36%14.92M16.38% Operating profit -296.30M---360.94M21.82%-375.11M3.93%-291.06M22.41% Profit before tax -311.80M---383.17M22.89%-387.93M1.24%-305.97M21.13% Net profit -311.80M---383.17M22.89%-387.93M1.24%-305.97M21.13% Net profit attributable to owners -310.99M---382.43M22.97%-386.95M1.18%-299.77M22.53%

Revenue 0--0-- Other income and gains 20.82M--142.34M583.68% Cost of sales 0--0-- Gross profit 0--0-- Administrative expenses 38.77M--62.55M61.33% Net finance costs 7.35M--7.83M6.50% Income tax 0--0-- Share of associates and JVs 0---3.83M-- Profit before tax -114.06M---26.88M76.43% Net profit -114.06M---26.88M76.43% Net profit attributable to owners -112.18M---24.90M77.81%

Cash and cash equivalents 90.76M--186.83M105.85%460.46M146.46%367.29M20.24% Total current assets 274.73M--233.71M14.93%568.98M143.45%441.04M22.48% Total assets 558.36M--573.14M2.65%915.69M59.77%779.74M14.85% Total current liabilities 962.24M--1.30B35.20%289.08M77.78%307.77M6.47% Total liabilities 1.06B--1.45B37.21%443.13M69.51%493.13M11.28% Equity attributable to owners -505.94M---884.48M74.82%469.09M153.04%286.67M38.89% Total equity -500.75M---880.03M75.74%472.56M153.70%286.61M39.35%

Cash and cash equivalents ----201.96M-- Total current assets ----264.44M-- Total assets ----768.55M-- Total current liabilities ----252.68M-- Total liabilities ----507.79M-- Equity attributable to owners ----260.96M-- Total equity ----260.76M--

Net cash from operating activities -220.05M---200.94M8.68%-308.25M53.40%-215.77M30.00% Net cash from investing activities -158.16M--73.01M146.16%-135.86M286.09%35.95M126.46% Net cash from financing activities 351.14M--224.00M36.21%632.08M182.18%126.38M80.01% Net change in cash -27.08M--96.06M454.74%187.97M95.68%-53.43M128.43%

Net cash from operating activities -----91.25M-- Net cash from investing activities -----22.72M-- Net cash from financing activities -----4.30M--